Technical Analysis for FRLN - Freeline Therapeutics Holdings plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/29/2024
Freeline is a clinical-stage biotechnology company focused on AAV-based gene therapy targeting the liver. Its vision is to create better lives for people suffering from chronic, systemic diseases using the potential of gene therapy as a one-time treatment to provide a potential functional cure. Freeline is headquartered in the U.K. and has operations in Germany and the U.S.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Medical Genetics Applied Genetics Gene Delivery Gene Therapy Of The Human Retina Systemic Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Medical Genetics Applied Genetics Gene Delivery Gene Therapy Of The Human Retina Systemic Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 8.7 |
52 Week Low | 2.11 |
Average Volume | 18,474 |
200-Day Moving Average | 4.58 |
50-Day Moving Average | 6.40 |
20-Day Moving Average | 6.43 |
10-Day Moving Average | 6.45 |
Average True Range | 0.05 |
RSI (14) | 60.94 |
ADX | 39.22 |
+DI | 20.24 |
-DI | 8.46 |
Chandelier Exit (Long, 3 ATRs) | 6.33 |
Chandelier Exit (Short, 3 ATRs) | 6.52 |
Upper Bollinger Bands | 6.49 |
Lower Bollinger Band | 6.38 |
Percent B (%b) | 0.91 |
BandWidth | 1.79 |
MACD Line | 0.04 |
MACD Signal Line | 0.04 |
MACD Histogram | -0.0022 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.50 | ||||
Resistance 3 (R3) | 6.50 | 6.49 | 6.49 | ||
Resistance 2 (R2) | 6.49 | 6.49 | 6.49 | 6.49 | |
Resistance 1 (R1) | 6.49 | 6.49 | 6.49 | 6.49 | 6.49 |
Pivot Point | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 |
Support 1 (S1) | 6.48 | 6.48 | 6.48 | 6.48 | 6.47 |
Support 2 (S2) | 6.47 | 6.48 | 6.47 | 6.47 | |
Support 3 (S3) | 6.47 | 6.47 | 6.47 | ||
Support 4 (S4) | 6.47 |